MetLife Investment Advisors »

Xeris Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $169k 59k 2.85
2024-06-30 $186k 83k 2.25
2023-12-31 $167k 71k 2.35
2023-09-30 $133k 71k 1.86
2023-03-31 $116k 71k 1.63
2022-12-31 $34k 26k 1.33
2022-09-30 $111k 71k 1.57
2022-06-30 $109k 71k 1.54